In his new book, journalist Richard Harris writes that lack of reproducibility in research poses a serious threat to science.

Scientists in the United Kingdom react to the reality of Brexit, a U.S. Supreme Court nominee apologizes for ruling against the family of a boy with autism, and a Rett syndrome researcher is racking up awards.

Young adults with autism face many new expectations and challenges — with none of the support that is available during high school.

Clashing visions for the March for Science are muddying the event’s message, biomedical funding cuts do not put America first, and a rule restricting research on human embryos needs a revamp.

Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act.

President Trump’s spending plan — running into opposition from Republicans and Democrats alike — would cut about 20 percent of the roughly $30 billion budget of the U.S. medical research agency.

Donald Trump’s budget blueprint calls for considerable cuts to science agencies, CRISPR corrects mutations in human embryos, and a documentary highlights the challenges faced by an adult with autism.

Scott Gottlieb, nominated to lead the U.S. Food and Drug Administration has deep ties to industry, and has worn many other hats in his career.

Telehealth services may boost access to care, but they don’t save money, according to a new study.

Building on weeks of mounting pressure to address high prescription drug prices, three influential U.S. senators have asked the government’s accountability arm to probe the orphan drug program for potential misuse.